Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | NASCIMENTO, Larissa Vilela | |
dc.contributor.author | NETO, Francisco Lotufo | |
dc.contributor.author | MOREIRA, Dalmo Antonio Ribeiro | |
dc.contributor.author | CERUTTI, Virginia Braga | |
dc.contributor.author | THUROW, Helena Strelow | |
dc.contributor.author | BASTOS, Gisele Medeiros | |
dc.contributor.author | FERREIRA, Eric Batista | |
dc.contributor.author | HIRATA, Rosario Dominguez Crespo | |
dc.contributor.author | HIRATA, Mario Hiroyuki | |
dc.date.accessioned | 2022-08-12T17:14:56Z | |
dc.date.available | 2022-08-12T17:14:56Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Aim: This study investigated the influence of antidepressant drugs on methylation status of KCNE1, KCNH2 and SCN5A promoters and ECG parameters in adult psychiatric patients. Materials & methods: Electrocardiographic evaluation (24 h) and blood samples were obtained from 34 psychiatric patients before and after 30 days of antidepressant therapy. Methylation of promoter CpG sites of KCNE1, KCNH2 and SCN5A was analyzed by pyrosequencing. Results: Three CpG and four CpG sites of KCNE1 and SCN5A, respectively, had increased % methylation after treatment. Principal component analysis showed correlations of the methylation status with electrocardiographic variables, antidepressant doses and patient age. Conclusion: Short-term treatment with antidepressant drugs increase DNA methylation in KCNE1 and SCN5A promoters, which may induce ECG alterations in psychiatric patients. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | FAPESP [2016/12899-6] | |
dc.description.sponsorship | CNPq [302733/2016-7] | |
dc.description.sponsorship | CAPES [Code 001] | |
dc.identifier.citation | EPIGENOMICS, v.14, n.14, p.851-864, 2022 | |
dc.identifier.doi | 10.2217/epi-2022-0089 | |
dc.identifier.eissn | 1750-192X | |
dc.identifier.issn | 1750-1911 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/48553 | |
dc.language.iso | eng | |
dc.publisher | FUTURE MEDICINE LTD | eng |
dc.relation.ispartof | Epigenomics | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright FUTURE MEDICINE LTD | eng |
dc.subject | antidepressant drugs | eng |
dc.subject | cardiac arrhythmias | eng |
dc.subject | DNA methylation | eng |
dc.subject | pharmacoepigenetics | eng |
dc.subject | pyrosequencing | eng |
dc.subject.other | torsades-de-pointes | eng |
dc.subject.other | qt-prolongation | eng |
dc.subject.other | risk | eng |
dc.subject.other | epigenetics | eng |
dc.subject.other | tools | eng |
dc.subject.other | focus | eng |
dc.subject.wos | Genetics & Heredity | eng |
dc.title | Influence of antidepressant drugs on DNA methylation of ion channels genes in blood cells of psychiatric patients | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.author.external | NASCIMENTO, Larissa Vilela:Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil | |
hcfmusp.author.external | MOREIRA, Dalmo Antonio Ribeiro:Inst Dante Pazzanese Cardiol, Dept Electrophysiol & Cardiac Arrhythmias, BR-04012909 Sao Paulo, Brazil | |
hcfmusp.author.external | CERUTTI, Virginia Braga:Inst Dante Pazzanese Cardiol, Dept Electrophysiol & Cardiac Arrhythmias, BR-04012909 Sao Paulo, Brazil | |
hcfmusp.author.external | THUROW, Helena Strelow:Real & Benemerita Assoc Portuguesa Beneficiencia, Dept Teaching & Res, BR-01323001 Sao Paulo, Brazil | |
hcfmusp.author.external | BASTOS, Gisele Medeiros:Real & Benemerita Assoc Portuguesa Beneficiencia, Dept Teaching & Res, BR-01323001 Sao Paulo, Brazil | |
hcfmusp.author.external | FERREIRA, Eric Batista:Univ Fed Alfenas, Inst Exact Sci, BR-37130001 Alfenas, Brazil | |
hcfmusp.author.external | HIRATA, Rosario Dominguez Crespo:Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil | |
hcfmusp.author.external | HIRATA, Mario Hiroyuki:Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 1 | |
hcfmusp.contributor.author-fmusphc | FRANCISCO LOTUFO NETO | |
hcfmusp.description.beginpage | 851 | |
hcfmusp.description.endpage | 864 | |
hcfmusp.description.issue | 14 | |
hcfmusp.description.volume | 14 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 35818955 | |
hcfmusp.origem.scopus | 2-s2.0-85135198124 | |
hcfmusp.origem.wos | WOS:000823053000001 | |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Alegria M, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0969-9 | eng |
hcfmusp.relation.reference | Barro-Soria R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4750 | eng |
hcfmusp.relation.reference | Bazett HC, 1920, J PHYSIOL-LONDON, V53, P320, DOI 10.1113/jphysiol.1920.sp001881 | eng |
hcfmusp.relation.reference | Behlke LM, 2020, CNS DRUGS, V34, P1133, DOI 10.1007/s40263-020-00763-z | eng |
hcfmusp.relation.reference | Boyadjieva N, 2012, J PHARM PHARMACOL, V64, P1349, DOI 10.1111/j.2042-7158.2012.01475.x | eng |
hcfmusp.relation.reference | Correll CU., 2021, J CLIN PSYCHIAT, V82, pMY20096AH1C | eng |
hcfmusp.relation.reference | Cubeddu LX, 2016, CURR CARDIOL REV, V12, P141, DOI 10.2174/1573403X12666160301120217 | eng |
hcfmusp.relation.reference | Desai N, 2015, INDIAN J PSYCHIAT, V57, P305, DOI 10.4103/0019-5545.166619 | eng |
hcfmusp.relation.reference | Ferreira HJ, 2018, METHODS MOL BIOL, V1766, P49, DOI 10.1007/978-1-4939-7768-0_4 | eng |
hcfmusp.relation.reference | Fiori LM, 2018, PROG MOL BIOL TRANSL, V158, P255, DOI 10.1016/bs.pmbts.2018.04.004 | eng |
hcfmusp.relation.reference | Garcia-Elias A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030692 | eng |
hcfmusp.relation.reference | Gintant GA, 2011, BRIT J PHARMACOL, V164, P254, DOI 10.1111/j.1476-5381.2011.01433.x | eng |
hcfmusp.relation.reference | Goldberg JF., 2021, J CLIN PSYCHIAT, V82 | eng |
hcfmusp.relation.reference | Grundmann M, 2015, BIOMED PAP, V159, P35, DOI 10.5507/bp.2013.020 | eng |
hcfmusp.relation.reference | Hack LM, 2019, J AFFECT DISORDERS, V249, P336, DOI 10.1016/j.jad.2019.02.009 | eng |
hcfmusp.relation.reference | Hoehe MR, 2018, DIALOGUES CLIN NEURO, V20, P169 | eng |
hcfmusp.relation.reference | Houseman E Andres, 2015, Curr Environ Health Rep, V2, P145, DOI 10.1007/s40572-015-0050-3 | eng |
hcfmusp.relation.reference | Houtepen LC, 2016, EPIGENOMICS-UK, V8, P197, DOI 10.2217/epi.15.98 | eng |
hcfmusp.relation.reference | Jacobson I, 2011, J PHARMACOL TOX MET, V63, P40, DOI 10.1016/j.vascn.2010.04.010 | eng |
hcfmusp.relation.reference | Jain Rakesh, 2017, J Clin Psychiatry, V78, P1091, DOI 10.4088/JCP.su17009ah1c | eng |
hcfmusp.relation.reference | Johannesen L, 2014, CLIN PHARMACOL THER, V95, P501, DOI 10.1038/clpt.2013.238 | eng |
hcfmusp.relation.reference | Kahl KG, 2022, FRONT PSYCHIATRY, V13, DOI 10.3389/fpsyt.2022.831359 | eng |
hcfmusp.relation.reference | Kanherkar RR, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/8929057 | eng |
hcfmusp.relation.reference | Lu HR, 2013, J PHARMACOL TOX MET, V68, P250, DOI 10.1016/j.vascn.2013.01.003 | eng |
hcfmusp.relation.reference | Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80 | eng |
hcfmusp.relation.reference | Manikandan P, 2018, CURR DRUG TARGETS, V19, P38, DOI 10.2174/1389450118666170125144557 | eng |
hcfmusp.relation.reference | Medeiros-Domingo A, 2007, REV ESP CARDIOL, V60, P739, DOI 10.1157/13108280 | eng |
hcfmusp.relation.reference | Muensterman ET, 2018, PHARMACOTHERAPY, V38, P813, DOI 10.1002/phar.2146 | eng |
hcfmusp.relation.reference | Ohya S, 2016, PHARMACOL THERAPEUT, V160, P11, DOI 10.1016/j.pharmthera.2016.02.001 | eng |
hcfmusp.relation.reference | Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016 | eng |
hcfmusp.relation.reference | Prasitlumkum N, 2021, J AM COLL CARDIOL, V77, P290, DOI 10.3390/medsci9020026 | eng |
hcfmusp.relation.reference | Schuebel K, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw058 | eng |
hcfmusp.relation.reference | Stella F, 2018, CURR DRUG METAB, V19, P641, DOI 10.2174/1389200219666171227203225 | eng |
hcfmusp.relation.reference | Swenson RS, 2020, J AM PSYCHIAT NURSES, V26, P344, DOI 10.1177/1078390319873049 | eng |
hcfmusp.relation.reference | Vicente J, 2018, CLIN PHARMACOL THER, V103, P54, DOI 10.1002/cpt.896 | eng |
hcfmusp.relation.reference | Webb LM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030826 | eng |
hcfmusp.relation.reference | Wenzel-Seifert K, 2011, DTSCH ARZTEBL INT, V108, P687, DOI 10.3238/arztebl.2011.0687 | eng |
hcfmusp.relation.reference | Wilde AAM, 2018, JACC-CLIN ELECTROPHY, V4, P569, DOI 10.1016/j.jacep.2018.03.006 | eng |
hcfmusp.relation.reference | Zhang L, 2020, ADV EXP MED BIOL, V1253, P3, DOI 10.1007/978-981-15-3449-2_1 | eng |
hcfmusp.relation.reference | Zimmermann N, 2012, BIOCHEM J, V448, P93, DOI 10.1042/BJ20120674 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | fe1423c6-860b-4740-972f-5b133a8cec31 | |
relation.isAuthorOfPublication.latestForDiscovery | fe1423c6-860b-4740-972f-5b133a8cec31 |